Skip to content

Clinical study on the treatment of chronic persistent stage of bronchial asthma with the method of Jieyu Sufei Decoction

Clinical study on the treatment of chronic persistent stage of bronchial asthma with the method of Jieyu Sufei Decoction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032153
Enrollment
Unknown
Registered
2020-04-21
Start date
2020-05-11
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Sponsors

Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of Western medicine met the criteria of "chronic duration of bronchial asthma"; 2. The syndrome differentiation of traditional Chinese medicine was qi stagnation, blood stasis and phlegm coagulation; 3. The age was between 18-75 years old; 4. The patients did not participate in the clinical research of other intervention measures within one month before selection; 5. The volunteers.

Exclusion criteria

Exclusion criteria: 1. Serious diseases such as cardiovascular system, digestive system, respiratory system, blood system and nervous system with clinical significance; 2. Pregnant or lactating women, women preparing for pregnancy in the past three months or men preparing for pregnancy; 3. Psychotic patients, those who do not cooperate with the test; 4. History of chronic alcoholism or drug abuse or any cause affecting compliance; 5. Those who participated in other clinical trials within one month; 6. Who had acute asthma in the first week before the group; 7. Who had allergic history to Jieyu Sufei formula, salmeterol / ticasone or montelukast sodium.

Design outcomes

Secondary

MeasureTime frame
Symptom quantification score;Anxiety and depression scale;Pulmonary function test;Eosinophils in blood ;IgE;

Primary

MeasureTime frame
Asthma control grade;ACT score;

Countries

China

Contacts

Public ContactHe Yi

Xiyuan Hospital of China Academy of Chinese Medical Sciences

clampharry@sohu.com+86 13520840043

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026